Net sales and profitability at the level of the comparison period, cash flow continued to strengthen
FINANCIAL DEVELOPMENT IN BRIEF
JANUARY-MARCH 2024, CONTINUING OPERATIONS
** The Group's net sales totalled
** Comparable EBITDA was
** EBITDA was
** Comparable EBIT was
** EBIT was
** The Group's cash flow from continuing operations after financial items and taxes totalled
** The comparable return on invested capital (ROIC) was 7.4 (6.4) per cent and the return on invested capital (ROIC) was 6.3 (6.0) per cent.
** Comparable earnings per share were
** Earnings per share were
*EBITDA and EBIT include
CEO PEKKA KUUSNIEMI:
The market environment has begun to show signs of stabilisation during the first quarter of the year. Volumes have stopped falling and, especially in the B2B sector, we are seeing a gradual increase in order volumes. Uncertainty is sustained by the protracted war in
Net sales were practically on a par with the previous year,
Cash flow improved significantly, reaching
The cholesterol-lowering category has seen fierce price campaigning as consumers become more price-conscious. For Benecol® products, the first quarter was cautiously positive as the volume decline levelled off. Raisio is increasingly collaborating with healthcare professionals to raise awareness of Benecol® products. The
Sales of oat products have increased in both the B2C and B2B markets. Elovena®, which will celebrate its centenary next year, has entered the Dutch and Belgian markets during the period, in addition to its previous foreign markets in
The iconic Elovena® received a great recognition in March: According to the Sustainable Brand Index, consumers rank Elovena® as the most sustainable brand in
The plant protein category has fared poorly under the pressures of COVID-19 and inflation. This phenomenon is not limited to the Finnish market, where Härkis® is the leading brand;
As the economy improves, the food market will certainly return to normal. Raisio has overcome difficult times before, staying true to its strategy. Our employees have embraced the company's purpose and values as part of their daily work and are each developing the company in line with the strategy. My heartfelt thanks to all of you!
OUTLOOK 2024
Raisio projects the comparable EBIT for the financial year 2024 to be at the level of 2023 or slightly higher. Raisio's comparable EBIT in 2023 was
In
Board of Directors
Further information:
Pekka Kuusniemi, CEO, tel. +358 50 537 3883
The CEO's webcast in Finnish of the Q1 results will start on
Future financial releases of
** Raisio's Half-Year Financial Report for January-June will be published on
** Raisio's Interim Report for January-September will be published on
At Raisio, we make food from the heart, with the aim of bringing health to ourselves and the Earth. We keep creating better plant-based and heart-healthy products so that eating healthily and within the Earth's ecological capacity can be a pleasure. Our strong brands, such as Benecol®, Härkis® and Elovena®, turn our ambitions into reality. Through our responsibility work, we make the hard choices for consumers, so that they can choose Raisio products with confidence. We have around 350 healthy food colleagues in seven countries and export to more than 40 markets around the world. Raisio's shares are listed on
https://news.cision.com/raisio-oyj/r/raisio-plc-s-interim-report-january-march-2024,c3974492
https://mb.cision.com/Main/19289/3974492/2781836.pdf
(c) 2024 Cision. All rights reserved., source